Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

AZ divests European rights for cholesterol med Crestor to Grünenthal

Grünenthal will pay up to $350m for the rights

- PMLiVE

Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda

Trial will test therapeutic candidates in hospitalised COVID-19 patients

- PMLiVE

Moderna eyes COVID-19 vaccine approval in the US and the EU

Updated analysis demonstrates efficacy of 94.1%

- PMLiVE

Winter is coming

It is important to look after our mental and physical health while working from home

- PMLiVE

AZ, Oxford University face more scrutiny over COVID-19 vaccine data

WHO’s immunisations director says ‘more than a press release’ is needed

Webcast

The power of a good story: Turn your insights into effective storytelling with data visualisation

Inizio

- PMLiVE

COVID-19 infections in England drop by 30% amid national lockdown

Observations come from REACT study led by Imperial College London and Ipsos MORI

- PMLiVE

Moderna and UK sign agreement for additional doses of COVID-19 vaccine

The UK has secured another two million doses on top of previously agreed five million doses

- PMLiVE

Biogen signs $3.1bn deal with Sage for potential depression therapies

Zuranolone already has a breakthrough therapy designation from the US FDA

- PMLiVE

What Next?

Insights To Support Post Pandemic Heath Communications

- PMLiVE

The important role of CROs in shaping the future of clinical research across Europe

Looking at the impact of COVID-19 on clinical research activities

- PMLiVE

Be careful what you wish for

Ten months into this pandemic, it seems a lot of people are hoping for some strange things

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links